Acorns Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Acorns Advisers's LLY Position: Q2 2026 in Review
Acorns Advisers increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $265K and bringing the position to 2,555 shares worth $3.06M. The position accounts for 0.02% of the portfolio, ranked #35.
Acorns Advisers first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Acorns Advisers held 2,555 shares of Eli Lilly worth $3.06M as of Q2 2026.
- Acorns Advisers bought 259 Eli Lilly shares in Q2 2026, an estimated $265K.
- Eli Lilly made up 0.02% of Acorns Advisers's portfolio in Q2 2026, its #35 holding.
- Acorns Advisers first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Acorns Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.